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Background and Aims: The reported associated mortality risks of Acute Kidney Injury
(AKI) in the intensive care unit (ICU) are variable. Although the Kidney Disease
Improving Global Outcome (K-DIGO) improved harmonisation of the definition,
there is remaining variability in the actual implementation of this AKI definition, with
variable use of the urinary output (UO) criterion, and different interpretations of the
baseline serum creatinine (Screa). This hampers progress of our understanding of the
clinical concept AKI and leads to confusion and unclarity when interpreting models to
predict AKI associated outcomes. With the advent of big data and artificial intelligence
based decision algorithms, this problem will only become more of interest, as the user
will not know what exactly the construct AKI in the application used means. Therefore,
we intended to explore the impact of different interpretations of the Screa and the UO
criterium as presented in the K-DIGO definition on the associated ICU mortality risk
of AKI stage 2 in the ICU.
Method: We included all patients of an electronic health data system applied in a terti-
ary ICU between 2013 and 2017. Sequential Organ Failure Assessment (SOFA) score
was calculated, and gender, age, weight and mortality at ICU and in hospital were
extracted. All serum creatinine (sCrea) values during ICU stay and hospitalisation were
extracted, as were UO data, with their time stamps. In addition, all Screa data up to 1
year before ICU admission were retrieved from a dataset external to ICU. AKI was
defined according to KDIGO stage 2, using different possible interpretations of the
Screa and/or the UO criterion. For the evolution of Screa as compared to a baseline
value, we either used a value directly available to ICU staff (def 1), a presumed eGFR of
75ml/min (def 2), the first available value after admission to ICU (def 3), the lowest
value during the current hospitalisation before ICU admission (def 4), the lowest value
before the hospitalisation episode as found in an external dataset (def 5). For the UO
criterion, we used either (in line with K-DIGO stage 2) a UO below 6ml/kg during a 12
hour block (def 6) or a UO below 0.5ml/kg/hour during each of 12 consecutive one
hour intervals (def 7). Definition 8 and 9 identified patients who complied with at least
one out of the Screa criteria 1-5 (def 8) or out of the UO criteria (def 9). Definition 10
identified patients who complied both with at least one Screa and one UO criterium.
Results: Our dataset comprised 16433 admissions (34.7% female, age 60.7616.4 years).
Overall, 8.1% of patients died in Intensive Care Unit (ICU). The SOFA score at admis-
sion was 6.964.1. The mortality risk associated with AKI according to the stage 2 defi-
nition of K-DIGO varied according to the interpretation of the diagnostic criteria
(table). Most important, associated mortality risk was comparable whether a UO (RR
2.31, 95% CI 1.90-2.81) or a Screa (RR 2.00, 95% CI 1.57-2.55) criterium was used, and
was highest in patients who complied with both at least one UO and one Screa crite-
rium (RR 7.28, 95% CI 6.12-8.65).
Conclusion: Unclarity on the actual interpretation of the Screa and UO criteria used in
the K-DIGO definition of AKI leads to substantial differences in AKI associated mortal-
ity risk. Omitting the UO criterium leads to substantial underestimation of associated
risk.
Figure: mortality according to different interpretations of the Screa and UO criteria of
K-DIGO AKI stage 2
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